Technology News and Research

RSS

Interventional Spine to present at and participate as sponsor of Spine Technology Summit

Interventional Spine, Inc., a privately held medical device manufacturer focusing on diseases of the spine, will present at the Spine Technology Summit at the Roosevelt Hotel in New Orleans on Monday April 26th. This annual event is a showcase for 40 new technology companies and attracts investors, industry, practitioners and analysts.

22 Apr 2010

Helen F. Graham Cancer Center at Christiana Care receives $2.8M to extend cancer research

The Helen F. Graham Cancer Center at Christiana Care is the recipient of $2.8 million from the National Cancer Institute, part of the National Institutes of Health, to expand cancer research.

22 Apr 2010

Life sciences companies shifting away from traditional document management systems to emerging ECC solutions

Virtify, Inc., today announced the availability of a new IDC Health Insights study titled "Managing Paper at Its Roots: Extending Beyond Document Management to Enterprise Content Compliance." The new IDC Health Insights study, which was commissioned by Virtify, shows a growing trend in the life sciences industry away from traditional document management systems to emerging Enterprise Content Compliance (ECC) solutions.

22 Apr 2010

KSERA research project focuses on COPD patients

To enable elderly people to live at home as long as possible, a group of European researchers, coordinated from Eindhoven University of Technology, will link robots and 'smart homes'. The robot, a 'sensible family friend', will ensure that home is a nice place to stay. And that patients do the right things.

22 Apr 2010

A-Life Medical signs exclusive agreement with Drs. Hill & Thomas

A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding products and services to the healthcare industry, announced today the forging of an exclusive agreement with the oldest and largest independently owned radiology group in Ohio, Cleveland-based Drs. Hill & Thomas Co.

22 Apr 2010

New insight into mechanism regulating early mammalian development

Scientists at the Genome Institute of Singapore (GIS) have recently generated significant single cell expression data crucial for a detailed molecular understanding of mammalian development from fertilization to embryo implantation, a process known as the preimplantation period. The knowledge gained has a direct impact on clinical applications in the areas of regenerative medicine and assisted reproduction.

22 Apr 2010

Autonomy, Kainos release Evolve Electronic Document Management solution

Autonomy Corporation plc, a global leader in infrastructure software for the enterprise, and Kainos, a leading IT consulting company, today announced the launch of Evolve™, a next-generation Electronic Document Management solution which enables instant and secure access to patient medical records through Autonomy's unique Meaning Based Computing solutions. The new system is already being trail blazed by Ipswich Hospital NHS Trust and is the successful outcome of months of collaboration between Kainos and Autonomy.

22 Apr 2010

GUMC researchers awarded grant to discover and develop new smoking cessation drugs

A Georgetown University Medical Center research team has been awarded a grant from the National Institute on Drug Abuse to discover and develop new smoking cessation drugs based on an unconventional theory about nicotine addiction. Kenneth Kellar, PhD, a professor of pharmacology at GUMC is principal investigator of the five year grant totaling $4.6 million.

22 Apr 2010

Alnylam Pharmaceuticals presents new data on ALN-TTR01 RNAi therapeutic at amyloidosis symposium

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, presented new pre-clinical data from its ALN-TTR program at the XII International Symposium on Amyloidosis in Rome on April 18 - 21, 2010. ALN-TTR01 is a systemically delivered RNAi therapeutic being developed for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), including familial amyloidotic polyneuropathy (FAP) and familial amyloidotic cardiomyopathy (FAC).

22 Apr 2010

MRSA infections on the rise in hospitals and health care settings: AHRQ report

Despite activities to identify and reduce the spread of methicillin-resistant Staphylococcus aureus (MRSA) and other health care-associated infections in hospitals and health care settings nationwide, new reports released by the Agency for Healthcare Research and Quality show that MRSA is on the rise and continues to pose an alarming threat.

22 Apr 2010

Immunomedics reports on ribonuclease-based immunotoxin development at AACR meeting

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported results from two studies on the development of ribonuclease-based immunotoxins at the American Association for Cancer Research conference.

22 Apr 2010

Swine flu vaccine blues

Exactly a year after the swine flu outbreak vigilance, newer vaccine techniques and other measures are being emphasized by researchers and key decision makers. Dr. Harvey Fineberg, chairman of the World Health Organization's pandemic review committee and President of the U.S. Institute of Medicine says, we need to look at the past to learn from it.

22 Apr 2010

Positive results from preclinical EP-302 program presented at AACR 2010

Drug discovery and development company Esperance Pharmaceuticals today presented positive results from their preclinical EP-302 program that support the initiation of IND enabling studies. EP-302 is a targeted membrane-disrupting peptide designed to selectively kill cells that express nucleolin on their surface. Nucleolin is a protein that is over-expressed in a wide range of cancers and tumor endothelial cells.

22 Apr 2010

Research findings may help personalize use of statins, scientists say

Researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have discovered why statins -- popular drugs that lower cholesterol and appear to protect against colorectal cancer development -- work for some people, but not for all.

22 Apr 2010

WaferGen Biosystems introduces SmartChip Multi-Sample Dispenser for faster biomarker validation

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genetic analysis systems, today announced that it has launched its SmartChip Multi-Sample Dispenser to enable significant speed and cost advantages for biomarker validation using gene expression and genotyping. The new SmartChip Multi-Sample Dispenser, which is part of the SmartChip Real-Time PCR System, can load up to 384 samples or sample replicates on a single SmartChip with its 5,184 nanowells, offering the highest number of samples that can be run on a nano-chip.

22 Apr 2010

Medical technology innovation strives for personal focus, cost-efficiency

Medtronic CEO Bill Hawkins says the products made by his company, like pacemakers, insulin pumps and neurostimulators are the "ultimate personal technologies," according to CNNMoney. He said a shift in his industry is moving towards health information technology that people will depend on and use with their cell phones and laptops.

22 Apr 2010

Manhattan Scientifics' early cancer detection technology offers better results than mammogram test

Manhattan Scientifics, Inc. announced today that its "early cancer detection" technology, developed by Edward R. Flynn, Ph.D. is expected to identify breast cancer three years earlier than the current gold standard mammogram test. Dr. Flynn is a pioneer in the emerging field of nano medicine.

22 Apr 2010

Sartorius Group's first-quarter consolidated sales revenue increases by 3.0% to 150.4 million euros

At today's Annual Shareholders' Meeting of the Sartorius technology group, CEO and Executive Board Chairman Dr. Joachim Kreuzburg presented the consolidated results for the first three months of 2010. The Biotechnology Division, which operates under the name Sartorius Stedim Biotech and contributes a good two-thirds to consolidated sales, started off the year 2010 by reporting growth and further profitability gains again.

From Sartorius 22 Apr 2010

MedAssets, Cullman Regional Medical Center announce transformational revenue cycle agreement

MedAssets, Inc. today announced that it entered into a transformational revenue cycle agreement with Cullman Regional Medical Center, based in Cullman, Ala. to improve the provider's business office operations.

22 Apr 2010

Genmab introduces new pre-clinical antibody program and novel bispecific antibody technology

Genmab A/S will announce today at its Annual General Meeting a new pre-clinical antibody program, HuMax-cMet,as well as a novel next generation bispecific antibody technology.

22 Apr 2010

Technology News and Research

Interventional Spine to present at and participate as sponsor of Spine Technology Summit

Helen F. Graham Cancer Center at Christiana Care receives $2.8M to extend cancer research

Life sciences companies shifting away from traditional document management systems to emerging ECC solutions

KSERA research project focuses on COPD patients

A-Life Medical signs exclusive agreement with Drs. Hill & Thomas

New insight into mechanism regulating early mammalian development

Autonomy, Kainos release Evolve Electronic Document Management solution

GUMC researchers awarded grant to discover and develop new smoking cessation drugs

Alnylam Pharmaceuticals presents new data on ALN-TTR01 RNAi therapeutic at amyloidosis symposium

MRSA infections on the rise in hospitals and health care settings: AHRQ report

Immunomedics reports on ribonuclease-based immunotoxin development at AACR meeting

Swine flu vaccine blues

Positive results from preclinical EP-302 program presented at AACR 2010

Research findings may help personalize use of statins, scientists say

WaferGen Biosystems introduces SmartChip Multi-Sample Dispenser for faster biomarker validation

Medical technology innovation strives for personal focus, cost-efficiency

Manhattan Scientifics' early cancer detection technology offers better results than mammogram test

Sartorius Group's first-quarter consolidated sales revenue increases by 3.0% to 150.4 million euros

MedAssets, Cullman Regional Medical Center announce transformational revenue cycle agreement

Genmab introduces new pre-clinical antibody program and novel bispecific antibody technology

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News